SEC Company Response from Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083) (SNOA) — Nov 21, 2017
Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083)
Date: Nov. 21, 2017 · CIK: 0001367083 · Accession: 0001683168-17-003134
AI Filing Summary & Sentiment
File numbers found in text: 333-221477
Show Raw Text
CORRESP
1
filename1.htm
November 21, 2017
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E., Mail Stop 3561
Washington, D.C. 20549
Attn:
Chris Edwards
Re:
Sonoma Pharmaceuticals, Inc.
Registration Statement on Form S-3, as amended
Filed November 9, 2017, and amended on November
17, 2017
File No. 333-221477
Acceleration Request
Requested Date: November 27, 2017
Requested Time: 4:00 P.M. EST
Dear Mr. Edwards:
Pursuant to Rule 461 of the Rules and Regulations
promulgated under the Securities Act of 1933, as amended, Sonoma Pharmaceuticals, Inc. (the “Company”), hereby requests
that the above-captioned Registration Statement on Form S-3 (the “Registration Statement”) be accelerated to Monday,
November 27, 2017 at 4:00 p.m. EST or as soon as practicable thereafter.
The cooperation of the staff in meeting
our request is very much appreciated. Please call Amy Trombly at (617) 243-0060 if you have any questions or if we can otherwise
be of assistance to you.
Very truly yours,
/s/ Jim Schutz
By: Jim Schutz
Chief Executive Officer
cc: Amy Trombly, Esq.